Assessment of intention and hesitancy to receive a booster dose of COVID-19 vaccine among community pharmacists using a vaccine hesitancy scale

Basit Öğe Kaydı
dc.authoridALTAIE, Anmar/0000-0002-2183-6830
dc.authoridYILMAZ, ZEKIYE/0000-0002-0041-6140
dc.authorwosidALTAIE, Anmar/ITV-8235-2023
dc.contributor.authorAl-taie, Anmar
dc.contributor.authorYilmaz, Zekiye
dc.date.accessioned2024-05-19T14:39:32Z
dc.date.available2024-05-19T14:39:32Z
dc.date.issued2023
dc.departmentİstinye Üniversitesien_US
dc.description.abstractAimTo assess the patterns regarding COVID-19 infection and vaccination, along with the intention and hesitancy towards receiving a booster dose of the COVID-19 vaccine among community pharmacists in Istanbul, Turkiye.Subject and MethodsThis was a cross-sectional, descriptive study conducted using a three-part structured validated questionnaire among community pharmacists. Vaccine hesitancy from a booster dose of the COVID-19 vaccine was assessed using the Vaccine Hesitancy Scale.ResultsA total of 145 community pharmacists were included, with a mean age of 43.22 +/- 13.3 years. Ninety-eight percent of the respondents received the COVID-19 vaccine. Most of the participants reported significant agreement to receiving a booster dose of the vaccine (91.7%, P < 0.0001). There was a statistically significant correlation between the intention to receive a booster vaccine dose and female gender (P = 0.0008), pharmacy education degree (bachelor's degree; P < 0.0001), and work experience more than 10 years (P < 0.0001).ConclusionRegardless of side effects from the previous dose, most of pharmacists who received the COVID-19 vaccine reported an intention to receive the booster dose, which generally builds trust in vaccine acceptance and undoubtedly plays a significant role in the control of the COVID-19 pandemic.en_US
dc.identifier.doi10.1007/s10389-023-01968-4
dc.identifier.issn2198-1833
dc.identifier.issn1613-2238
dc.identifier.scopus2-s2.0-85161974033en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.urihttps://doi.org10.1007/s10389-023-01968-4
dc.identifier.urihttps://hdl.handle.net/20.500.12713/4799
dc.identifier.wosWOS:001009209400001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherSpringer Heidelbergen_US
dc.relation.ispartofJournal of Public Health-Heidelbergen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz20240519_kaen_US
dc.subjectBooster Doseen_US
dc.subjectCommunity Pharmacistsen_US
dc.subjectCovid-19en_US
dc.subjectPandemicen_US
dc.subjectSars-Cov-2en_US
dc.subjectVaccine Hesitancyen_US
dc.titleAssessment of intention and hesitancy to receive a booster dose of COVID-19 vaccine among community pharmacists using a vaccine hesitancy scaleen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu